Who Owns Heron Therapeutics Stock?
NASDAQ: HRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 12:39 PM ET
Ownership breakdown
- Held by institutions
- 71.00%
- Held by insiders
- 0.98%
- Institutional holders
- 204
- Institutions 71.0%
- Insiders 1.0%
- Public and other 28.0%
Who owns Heron Therapeutics stock?
Institutional investors own about 71.0% of Heron Therapeutics's shares, spread across 204 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.98% of HRTX.
The largest institutional holders are Rubric Capital Management LP (15.83%), Clearline Capital, LP (6.00%) and Blackrock Inc. (5.56%). Together, the top 10 institutions control 49.2% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their HRTX positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of HRTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Rubric Capital Management LP | 30.05M | 15.83% | 0.0% |
| Clearline Capital, LP | 11.38M | 6.00% | -7.0% |
| Blackrock Inc. | 10.55M | 5.56% | +4.4% |
| Velan Capital Investment Management LP | 8.75M | 4.61% | 0.0% |
| Vanguard Capital Management LLC | 7.78M | 4.10% | -0.3% |
| Tejara Capital Ltd | 6.51M | 3.43% | +2.8% |
| Tang Capital Management, LLC | 6.25M | 3.29% | 0.0% |
| Geode Capital Management, LLC | 4.27M | 2.25% | +6.5% |
| Millennium Management Llc | 4.07M | 2.14% | -46.7% |
| JW Asset Management, LLC | 3.75M | 1.98% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of HRTX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.47M | 2.88% |
| iShares Trust-iShares Russell 2000 ETF | 3.63M | 1.91% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.06M | 1.09% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.63M | 0.86% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.37M | 0.72% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 869.90K | 0.46% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 783.99K | 0.41% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 635.71K | 0.33% |
| iShares Trust-iShares Micro-Cap ETF | 533.80K | 0.28% |
| iShares Trust-iShares Russell 2000 Value ETF | 504.98K | 0.27% |
Frequently asked questions
Who is the largest shareholder of Heron Therapeutics?
Rubric Capital Management LP is the largest institutional shareholder of HRTX, owning 15.83% of shares outstanding (30.05M shares) as of its latest 13F filing.
What percentage of Heron Therapeutics is owned by institutions?
Institutions own about 71.0% of HRTX shares and 71.7% of the public float.
How much of Heron Therapeutics do insiders own?
Insiders, such as officers and directors, own about 0.98% of HRTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.